An overview of MYC and its interactome.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cold Spring Harbor Perspectives in Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/cshperspect.a014357PMID 24384812PMCID PMC3869278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Resolution Genomic Profiling of Chronic Lymphocytic Leukemia Reveals New Recurrent Genomic Alterations

  2014cited by this paper
• MYC and the art of microRNA maintenance.

  2014cited by this paper
• MYC degradation.

  2014cited by this paper
• Oncogenic mechanisms in Burkitt lymphoma.

  2014cited by this paper
• MYC and the control of DNA replication.

  2014cited by this paper
• MYC association with cancer risk and a new model of MYC-mediated repression.

  2014cited by this paper
• Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

  2014cited by this paper
• MYC cofactors: molecular switches controlling diverse biological outcomes.

  2014cited by this paper
• Socializing with MYC: cell competition in development and as a model for premalignant cancer.

  2014cited by this paper
• Therapeutic strategies to inhibit MYC.

  2014cited by this paper
• MYC regulation of cell growth through control of transcription by RNA polymerases I and III.

  2014cited by this paper
• c-MYC-induced genomic instability.

  2014cited by this paper
• MYC activation is a hallmark of cancer initiation and maintenance.

  2014cited by this paper
• Genome recognition by MYC.

  2014influential reference
• MYC and transcription elongation.

  2014cited by this paper
• Cellular MYCro economics: Balancing MYC function with MYC expression.

  2013cited by this paper
• EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.

  2013cited by this paper
• The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

  2013cited by this paper
• Neuroblastoma and MYCN.

  2013cited by this paper
• Mga, a dual‐specificity transcription factor that interacts with Max and contains a T‐domain DNA‐binding motif

  2013cited by this paper
• The role of MIZ-1 in MYC-dependent tumorigenesis.

  2013cited by this paper
• Myc function in Drosophila.

  2013influential reference
• Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks.

  2013influential reference
• Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila*

  2013cited by this paper
• Mondo/ChREBP-Mlx-Regulated Transcriptional Network Is Essential for Dietary Sugar Tolerance in Drosophila

  2013cited by this paper
• Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.

  2013cited by this paper
• Targeting MYCN in neuroblastoma by BET bromodomain inhibition.

  2013cited by this paper
• MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

  2013cited by this paper
• Selective inhibition of tumor oncogenes by disruption of super-enhancers.

  2013cited by this paper
• Role of MYC in Medulloblastoma.

  2013cited by this paper
• Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors

  2012cited by this paper
• Revisiting global gene expression analysis.

  2012cited by this paper
• Loss of Bmyc results in increased apoptosis associated with upregulation of Myc expression in juvenile murine testis.

  2012cited by this paper
• A Novel N-Terminal Domain May Dictate the Glucose Response of Mondo Proteins

  2012cited by this paper
• A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis

  2012influential reference
• High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

  2012cited by this paper
• c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation

  2011cited by this paper
• Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

  2011cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

  2011cited by this paper
• Evolution of the Max and Mlx Networks in Animals

  2011cited by this paper
• Targeting MYC dependence in cancer by inhibiting BET bromodomains

  2011cited by this paper
• Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.

  2011cited by this paper
• Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• Premetazoan ancestry of the Myc-Max network.

  2011cited by this paper
• A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.

  2010cited by this paper
• Glucose Controls Nuclear Accumulation, Promoter Binding, and Transcriptional Activity of the MondoA-Mlx Heterodimer

  2010cited by this paper
• Basic helix-loop-helix transcription factor gene family phylogenetics and nomenclature.

  2010cited by this paper
• Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells

  2010cited by this paper
• Myc, mondo, and metabolism.

  2010cited by this paper
• c-Myc regulates transcriptional pause release.

  2010cited by this paper
• Coordination of glucose and glutamine utilization by an expanded Myc network

  2010cited by this paper
• Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra

  2010cited by this paper
• An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.

  2010cited by this paper
• Myc Function in Drosophila.

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Myc proteins as therapeutic targets

  2010cited by this paper
• Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation.

  2010influential reference
• MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

  2009cited by this paper
• Gene Regulation and Epigenetic Remodeling in Murine Embryonic Stem Cells by c-Myc

  2009cited by this paper
• c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress

  2009cited by this paper
• Identification of Domains Responsible for Ubiquitin-Dependent Degradation of dMyc by Glycogen Synthase Kinase 3β and Casein Kinase 1 Kinases

  2009influential reference
• Glucose sensing by MondoA:Mlx complexes: A role for hexokinases and direct regulation of thioredoxin-interacting protein expression

  2008cited by this paper
• The c-myc promoter: still MysterY and challenge.

  2008cited by this paper
• Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1

  2008cited by this paper
• Myc's broad reach.

  2008cited by this paper
• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• Max-independent functions of Myc in Drosophila melanogaster

  2008cited by this paper
• Evolution of the holozoan ribosome biogenesis regulon

  2008cited by this paper
• Analysis of Myc-Induced Histone Modifications on Target Chromatin

  2008cited by this paper
• Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.

  2007cited by this paper
• P-TEFb is a Crucial Co-Factor for Myc Transactivation

  2007cited by this paper
• A Novel Role of the Mad Family Member Mad3 in Cerebellar Granule Neuron Precursor Proliferation

  2007cited by this paper
• Non-transcriptional control of DNA replication by c-Myc

  2007cited by this paper
• The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation

  2007cited by this paper
• A C. elegans Myc-like network cooperates with semaphorin and Wnt signaling pathways to control cell migration.

  2007cited by this paper
• Making myc.

  2006cited by this paper
• Inflammatory Disease and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells

  2006cited by this paper
• The Myc oncoprotein as a therapeutic target for human cancer.

  2006cited by this paper
• Of Myc and Mnt

  2006cited by this paper
• Myc-binding-site recognition in the human genome is determined by chromatin context

  2006cited by this paper
• Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

  2006cited by this paper
• The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.

  2006cited by this paper
• Global mapping of c-Myc binding sites and target gene networks in human B cells

  2006cited by this paper
• Articles on similar topics can be found in the following Blood collections Cell Cycle (231 articles)

  2006cited by this paper
• A Conserved Myc Protein Domain, MBIV, Regulates DNA Binding, Apoptosis, Transformation, and G2 Arrest

  2006cited by this paper
• B-myc: N-terminal recognition of myc binding proteins.

  2006cited by this paper
• Myc/Max/Mad in invertebrates: the evolution of the Max network.

  2006cited by this paper
• Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.

  2006cited by this paper
• Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function.

  2006cited by this paper
• c-Myc mediates pre-TCR-induced proliferation but not developmental progression.

  2006cited by this paper
• Mnt–Max to Myc–Max complex switching regulates cell cycle entry

  2005cited by this paper
• A conserved element in Myc that negatively regulates its proapoptotic activity

  2005cited by this paper
• The Transcriptional Repressor dMnt Is a Regulator of Growth in Drosophila melanogaster

  2005influential reference
• Nematode genome evolution.

  2005cited by this paper
• Two Rounds of Whole Genome Duplication in the Ancestral Vertebrate

  2005cited by this paper
• Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila.

  2005cited by this paper

• Medical detection of osteosarcoma biomarkers through machine learning and electrochemical sensors: the macromolecular mechanism of BAG2 and MGA proteins

  2026cites this paper
• Decoding MYC Targeted Inhibition in Cancer: Integrating Medicinal Insights With Computational Design Approaches

  2026cites this paper
• Functional nutrient-genetic profiling reveals biotin and FBXW7 are essential to bypass glutamine addiction.

  2026cites this paper
• Reactivation of the silenced BASP1 gene suppresses oncogenic WNT signaling in human colorectal cancer cells.

  2026cites this paper
• Study on the carcinogenic risk of food preservatives and their related molecular targets and pathway mechanisms through network toxicology analysis.

  2026cites this paper
• Diapause and Aging: Two opposing yet intertwined biological phenomena.

  2025cites this paper
• Phosphorylated Toll-like receptor 3 nuclear translocation in cancer cell promotes metastasis and chemoresistance

  2025cites this paper
• Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degeneration via autophagy and ageing in nucleus pulposus cells

  2025cites this paper
• Regulation of PEST-containing nuclear proteins in cancer cells: implications for cancer biology and therapy

  2025cites this paper
• A tumorigenesis threshold for endogenous Myc revealed by dosage-compensation for Myc-haploinsufficiency in the absence of p53

  2025cites this paper
• Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the 'Undruggable' MYC Oncogene and Potentiate Immune Checkpoint Blockage.

  2025cites this paper
• C‐Myc Indirectly Controls ATP13A2 Levels via HIF‐1α Activation

  2025cites this paper
• Targeting MYC with protein drugs.

  2025cites this paper
• Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes

  2025cites this paper
• MYC drives left-handed Z-DNA formation to shape gene expression

  2025cites this paper
• Brain Plasticity and Cell Competition: Immediate Early Genes Are the Focus

  2025cites this paper
• Beyond the Limit: MYC Mediates Tumor Immune Escape

  2025cites this paper
• Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering

  2025cites this paper
• An Integrative Drug‐Induced Transcriptomic Analysis Identifies Novel MYC Antagonists and Potential Synergistic Drug Combinations

  2025cites this paper
• The function of MYC in base excision repair protects against RAS-induced senescence

  2025cites this paper
• Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review

  2025cites this paper
• Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAFV600E/pTERT double mutated tumors

  2025cites this paper
• MYC in cancer: from undruggable target to clinical trials

  2025cites this paper
• Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells.

  2025cites this paper
• c-MYC mRNA destabilization inhibited lethal pancreatic cancer in vivo with significant survival outcomes

  2025cites this paper
• Targeting protein synthesis pathways in MYC-amplified medulloblastoma

  2025cites this paper
• Biology of PEST-containing nuclear proteins as potential targets in ovarian cancer (Review)

  2025cites this paper
• Discovery of a Pyrazolopyridinone-Based MYC Inhibitor That Selectively Engages Intracellular c-MYC and Disrupts MYC-MAX Heterodimerization.

  2025cites this paper
• Targeting MYC at the intersection between cancer metabolism and oncoimmunology

  2024cites this paper
• Manipulating Myc for reparative regeneration

  2024cites this paper
• Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis

  2024cites this paper
• Mutation Characteristics of the MYC Proximal Network and its Implications for Immunotherapy in Human Cancer

  2024cites this paper
• MYC the oncogene from hell: Novel opportunities for cancer therapy.

  2024cites this paper
• The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma

  2024cites this paper
• The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex.

  2024cites this paper
• Missense mutations in Myc Box I influence nucleocytoplasmic transport to promote leukemogenesis.

  2024cites this paper
• ALKBH5 promotes malignant proliferation of renal clear cell carcinoma by activating the MAPK pathway through binding to HNRNPDL.

  2024cites this paper
• Machine Learning of Three-Dimensional Protein Structures to Predict the Functional Impacts of Genome Variation

  2024cites this paper
• c-Myc Inhibition Induces an Additive Effect with Cyclophosphamide in Acute Lymphoblastic Leukemia

  2024cites this paper
• Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia

  2024cites this paper
• Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T cell proliferation

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology

  2024cites this paper
• Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes

  2024cites this paper
• Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis

  2024cites this paper
• In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer

  2024cites this paper
• Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma.

  2024cites this paper
• EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.

  2024cites this paper
• Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer

  2024cites this paper
• Regulation of lipid and serine metabolism by the oncogene c-Myc.

  2024cites this paper
• MYC-Mediated Inhibition of ARNT2 Uncovers a Key Tumor Suppressor in Glioblastoma

  2024cites this paper
• Mycb and Mych stimulate Müller glial cell reprogramming and proliferation in the uninjured and injured zebrafish retina

  2024cites this paper
• Directly Suppressing MYC Function with Novel Alkynyl-Substituted Phenylpyrazole Derivatives that Induce Protein Degradation and Perturb MYC/MAX Interaction.

  2024cites this paper
• Real-Time Measurement of a Weak Interaction of a Transcription Factor Motif with a Protein Hub at Single-Molecule Precision

  2024cites this paper
• Regulation of BCR-mediated Ca2+ mobilization by MIZ1-TMBIM4 safeguards IgG1+ GC B cell-positive selection

  2024cites this paper
• The C. elegans Myc-family of transcription factors coordinate a dynamic adaptive response to dietary restriction

  2024influential citation
• Immune evasion: An imperative and consequence of MYC deregulation

  2024cites this paper
• FABP6 serves as a new therapeutic target in esophageal tumor

  2024cites this paper
• The Engineered Drug 3′UTRMYC1-18 Degrades the c-MYC-STAT5A/B-PD-L1 Complex In Vivo to Inhibit Metastatic Triple-Negative Breast Cancer

  2024cites this paper
• m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling

  2024cites this paper
• System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy

  2024cites this paper
• Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks.

  2024cites this paper
• An oncoprotein CREPT functions as a co-factor in MYC-driven transformation and tumor growth

  2024cites this paper
• Regulation of MYC by CARD14 in human epithelium is a determinant of epidermal homeostasis and disease

  2024cites this paper
• A History of Cancer Research: Oncogenic Transcription Factors.

  2024cites this paper
• Основні транскрипційні фактори, які беруть участь у функціонуванні стовбурових клітин. Особливості їх активації та експресії в β-клітинах підшлункової залози (частина 2)

  2023cites this paper
• Structure-guided screening of protein-protein interaction for the identification of Myc-Max heterodimer complex modulators

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development

  2023cites this paper
• The role of alternative pre-mRNA splicing in cancer progression

  2023cites this paper
• MYC function and regulation in physiological perspective

  2023cites this paper
• MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

  2023cites this paper
• Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis

  2023cites this paper
• Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell Lines

  2023cites this paper
• Lessons in aging from Myc knockout mouse models

  2023cites this paper
• Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening

  2023influential citation
• Regulation of Gene Expression by the MYC Transcription Factor Network During Exercise

  2023influential citation
• Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers

  2023cites this paper
• Effects of adriamycin on cell differentiation and proliferation in rat testis

  2023cites this paper
• MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

  2023cites this paper
• KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma

  2023cites this paper
• c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis

  2023cites this paper
• High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein

  2023influential citation
• Novel mechanism of MYC deregulation in Multiple Myeloma

  2023cites this paper
• The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics

  2023influential citation
• Investigating In Situ Expression of c-MYC and Candidate Ubiquitin-Specific Proteases in DLBCL and Assessment for Peptidyl Disruptor Molecule against c-MYC-USP37 Complex

  2023cites this paper
• Strategies to target the cancer driver MYC in tumor cells

  2023influential citation
• CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression

  2023cites this paper
• pMyc and pMax Peptides Nanosystems and the Potential Treatment of Prostate Cancer, In Vitro Assays

  2023cites this paper
• ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner

  2023cites this paper
• The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells

  2023cites this paper
• Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc

  2023cites this paper
• Long Non-Coding RNAs as “MYC Facilitators”

  2023cites this paper
• The c-Myc targeting hnRNPAB promotes lung adenocarcinoma cell proliferation via stabilization of CDK4 mRNA.

  2023cites this paper
• AXL upregulates c‑Myc expression through AKT and ERK signaling pathways in breast cancers.

  2023cites this paper
• The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2

  2023cites this paper
• Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

  2023cites this paper
• When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases

  2023cites this paper